Literature DB >> 23828490

Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism.

Jian-Ping Cheng, Hong-Ni Yue, Shao-Gang Ma, Yue Jin, Wei Xu, Feng Bai.   

Abstract

AIM: To investigate the influence of overt hyperthyroidism and euthyroid congenital hypothyroidism on fasting glucagon-like peptide-1 (GLP-1) levels.
METHODS: A total of 30 untreated overt hyperthyroidism patients, 17 euthyroid congenital hypothyroidism children, and age- and sex-matched controls were enrolled. Levels of GLP-1, insulin, glucose, and homeostasis model assessment (HOMA-IR) were measured and evaluated.
RESULTS: Fasting GLP-1, blood glucose, insulin, and HOMR-IR levels were higher in patients with overt hyperthyroidism than in controls (p=0.030, p=0.008, p=0.004, p=0.037, respectively). These parameters in euthyroid hypothyroidism were similar to the controls. In euthyroid congenital hypothyroidism and overt hyperthyroidism patients, serum GLP-1 levels were not correlated with thyroid hormone, blood glucose, insulin, and HOMR-IR.
CONCLUSIONS: Fasting GLP-1 levels in the peripheral circulation were significantly increased in overt hyperthyroidism, however, they were no different in euthyroid congenital hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23828490     DOI: 10.1515/jpem-2013-0135

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis.

Authors:  Yue Jin; Hong Liu; Shao-Gang Ma; Jian-Ping Cheng; Kai Zhang
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

2.  Dyslipidemia and serum mineral profiles in patients with thyroid disorders.

Authors:  Abdelgayoum A Abdel-Gayoum
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.